List of Studies ( Metabolite:TG 18:1_20:1_26:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003760 | AN006174 | Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST002967 | AN004875 | Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
